This article provides an overview of recent advances in understanding the genetic basis of nicotine dependence, highlighting the role of GWAS and genetic fine-mapping in identifying key loci.
It discusses how these genetic insights can inform public health strategies and policies aimed at reducing smoking prevalence and related health risks.